D14 Neuromuscular function

Topic

Neuromuscular function tests evaluate the entire pathway connecting the central and peripheral nervous systems to the muscle, including the nerves, the neuromuscular junction, and the muscle fibers. Electroneurography and electromyography combine electrical stimulation of peripheral nerves with the recording of the muscle response and electrical activity—both at rest and during voluntary contraction.

Nerve conduction velocity is calculated by stimulating a nerve at two points and relating the distance between them to the difference in the onset time of the muscle response. According to the text, a velocity of less than 40 m/s predominantly indicates damage to the nerve's insulating sheath, as seen in Guillain-Barré syndrome and certain hereditary neuropathies. If the velocity remains normal but the response amplitude decreases, axonal damage predominates; this can occur in conditions such as amyotrophic lateral sclerosis, vasculitis, or specific types of poisoning. A localized prolongation of conduction time, with normal velocity along the rest of the nerve, indicates focal entrapment; for instance, a latency exceeding 4.5 ms in the nerve passing through the wrist may indicate carpal tunnel syndrome.

Electromyography allows for the correlation of electrical activity with muscle function. In a healthy muscle, there is a nearly proportional relationship between the surface electrical signal and the force produced when the muscle is operating at between approximately 20% and 80% of its maximum strength. This relationship enables the non-invasive estimation of force and the study of fatigue, as the correspondence between electrical activity and force changes progressively as the muscle fatigues.

The shape of motor unit potentials also helps localize the origin of the abnormality. In primary muscle diseases, such as polymyositis, the loss of fibers within each motor unit results in potentials of lower amplitude and shorter duration. In neuropathies, fibers that lose their innervation can be reinnervated by surviving neighboring neurons, forming larger motor units and generating potentials with greater-than-normal amplitude and duration.

Repetitive nerve stimulation specifically assesses the neuromuscular junction. Normally, there is a wide margin of safety: each release of acetylcholine generates a signal several times stronger than what is required to produce a contraction, meaning responses remain relatively constant during successive stimuli. In myasthenia gravis, antibodies against acetylcholine receptors reduce this margin. Upon stimulation at a rate of approximately three times per second, the muscle response progressively declines; according to the text, a decrease of more than 10% constitutes evidence of transmission failure. Neostigmine reduces acetylcholine degradation and can partially correct this decline by increasing its availability at the junction.

Grip strength, measured using a dynamometer, provides a simple functional assessment. According to the text, values ​​below 27 kg for men or 16 kg for women indicate insufficient muscle strength and constitute a mandatory criterion for diagnosing sarcopenia. This measurement also independently predicts disability, hospitalization, and mortality in individuals over the age of 65.

Evoked potentials assess more extensive pathways within the nervous system. Sensory potentials evaluate signal conduction to the brain via the long tracts of the spinal cord, while motor cortex stimulation allows for the study of descending conduction along the corticospinal tract. These tests are important for detecting abnormalities associated with multiple sclerosis and spinal cord injuries.

Taken together, neuromuscular tests allow for the localization of the source of weakness anywhere along the motor system. Conduction velocity and amplitude distinguish between demyelinating damage, axonal damage, and focal entrapments; electromyography differentiates between myogenic and neurogenic patterns; repetitive stimulation identifies neuromuscular junction failures; Grip strength quantifies functional loss, while evoked potentials assess pathways in the spinal cord and central nervous system. Together, they make it possible to determine whether an abnormality originates in the central pathways, the peripheral nerve, the neuromuscular junction, or the muscle fiber itself.

ID:2287